Joshua C Harrell

17PUBLICATIONS
52CO-AUTHORS
Molecular targetsSequence analysisLiquid biopsiesCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 03, 2026
Therapeutic synergies that overcome carboplatin resistance in triple-negative breast cancer.

Julia E Altman, Aaron Valentine, Nina Dashti-Gibson

|Jun 13, 2025
Advancing Antibody-Drug Conjugates: Precision Oncology Approaches for Breast and Pancreatic Cancers.

Dhanvin R Yajaman, Youngman Oh, Jose G Trevino

|Feb 20, 2025
Beyond Blacklists: A Critical Assessment of Exclusion Set Generation Strategies and Alternative Approaches.

Brydon P G Wall, Jonathan D Ogata, My Nguyen

|May 25, 2024
The Transformative Role of 3D Culture Models in Triple-Negative Breast Cancer Research.

Xavier S Bittman-Soto, Evelyn S Thomas, Madeline E Ganshert

|May 07, 2024
The Human Intermediate Prolactin Receptor I-tail Contributes Breast Oncogenesis by Targeting Ras/MAPK Pathway.

Shanwei Shen, Senthil K Radhakrishnan, J Chuck Harrell

|Apr 19, 2024
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations.

Funda Meric-Bernstam, Michael W Lloyd, Soner Koc

Pageof 3